Dr. Tolaney on Tailoring HER2-Directed Therapy in Breast Cancer

Sara M. Tolaney, MD, MPH, associate director, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, discusses tailoring HER2-directed therapies in the treatment of patients with breast cancer.

Dr. Tolaney on Tailoring HER2-Directed Therapy in Breast Cancer